EPISODE · Jan 28, 2026 · 27 MIN
Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib
from BiotechTV - News · host BiotechTV
He discusses learnings about durability, dosing, biomarkers, and more for this first-in-class target.
What this episode covers
He discusses learnings about durability, dosing, biomarkers, and more for this first-in-class target.
NOW PLAYING
Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m